Dr. David Camidge, MD – Aurora, CO
Brigatinib Versus Crizotinib in ALK-Positive Non–Small-Cell Lung Cancer
D Ross Camidge, Scott N Gettinger, Alexander Spira, The New England Journal of MedicineCorrelation of Extent of ALK FISH Positivity and Crizotinib Efficacy in Three Prospective Studies of ALK-Positive Patients with Non-Small Cell Lung Cancer
D R Camidge, A T Shaw, Annals of Oncology
